NovaBay Pharmaceuticals Inc

NovaBay Pharmaceuticals Inc is a US-based pharmaceutical company dedicated to developing and commercialising innovative eyecare and skincare products. Its aim is to address unmet therapeutic needs in ocular and dermatological health by bringing unique solutions to market. The company focuses on a broad range of consumer healthcare conditions. Operating within the healthcare and pharmaceutical sectors, NovaBay Pharmaceuticals Inc specialises in products leveraging hypochlorous acid (HOCl) technology. This proprietary approach offers antimicrobial and anti-inflammatory benefits, aiming to provide patients with effective and safe options for chronic conditions. Monitor the NBY share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.